AIM Vaccine Co., Ltd. (HKG:6660)

Hong Kong · Delayed Price · Currency is HKD

1.440

+0.050 (3.60%)

Jul 31, 2026, 3:59 PM HKT

AIM Vaccine Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,166	1,166	1,285	1,187	1,264	1,570
Revenue Growth	-7.67%	-9.29%	8.22%	-6.06%	-19.49%	-4.14%
Gross Profit	760.2	760.2	953.51	-611.21	1,028	1,295
Operating Income	-207.87	-207.87	-228.76	-2,000	-443.79	-648.73
Net Income	-675.46	-675.46	-277.23	-1,301	-319.6	-692.77
Earnings Per Share	-0.55	-0.55	-0.23	-1.07	-0.27	-0.60
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Chinese Mainland	1,165	1,165	1,278	1,187
Other Countries/Regions	0.38	0.38	6.81	-
Total	1,166	1,166	1,285	1,187

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	355.62	355.62	594.87	736.42	818.91	746.74
Total Debt	1,756	1,756	1,841	1,796	1,399	650.43
Net Cash (Debt)	-1,401	-1,401	-1,246	-1,059	-579.76	96.31
Net Cash Growth	-	-	-	-	-	-88.90%
Net Cash Per Share	-1.14	-1.14	-1.03	-0.87	-0.48	0.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	67.47	67.47	99.19	-165.5	-110.32	93.4
Capital Expenditures	-114.41	-114.41	-121.75	-158.92	-779.01	-1,125
Free Cash Flow	-46.93	-46.93	-22.56	-324.42	-889.33	-1,032
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	65.22%	65.22%	74.20%	-51.47%	81.30%	82.46%
Operating Margin	-17.83%	-17.83%	-17.80%	-168.43%	-35.11%	-41.32%
Pretax Margin	-65.76%	-65.76%	-22.62%	-191.22%	-34.35%	-38.64%
Profit Margin	-57.95%	-57.95%	-21.57%	-109.56%	-25.28%	-44.12%
FCF Margin	-4.03%	-4.03%	-1.75%	-27.32%	-70.35%	-65.73%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	6.52	8.06	13.82	31.06	-
PS Ratio	1.36	3.04	5.44	7.27	20.17	-